INVO Bioscience Announces Pricing of $4.5 Million Public Offering
/PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq:INVO) ("INVO" or the "Company"), a healthcare services fertility company focused on expanding access to advanced...
Stay updated with breaking news from Invo Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq:INVO) ("INVO" or the "Company"), a healthcare services fertility company focused on expanding access to advanced...
INVO Bioscience, Inc. (NASDAQ:INVO – Get Free Report) was the target of a significant decline in short interest in the month of July. As of July 15th, there was short interest totalling 290,600 shares, a decline of 38.8% from the June 30th total of 474,800 shares. Based on an average trading volume of 1,310,000 shares, […]
INVO Bioscience, Inc. (NASDAQ:INVO – Free Report) was the recipient of a large growth in short interest during the month of June. As of June 15th, there was short interest totalling 102,500 shares, a growth of 94.5% from the May 31st total of 52,700 shares. Based on an average daily volume of 1,120,000 shares, the […]
INVO Bioscience, Inc. (NASDAQ:INVO – Free Report) was the target of a large growth in short interest in June. As of June 15th, there was short interest totalling 102,500 shares, a growth of 94.5% from the May 31st total of 52,700 shares. Based on an average daily volume of 1,120,000 shares, the short-interest ratio is […]
Invo Bioscience (Nasdaq:INVO) announced that the FDA granted 510(k) clearance to expand the labeling on its InvoCell device.